Boardroom Alpha
Boardroom Alpha
RYAM · Current Report (Form 8-K) · Filed May 18, 2026

Rayonier Advanced Materials Inc — Current Report (Form 8-K)

Form
8-K
Filed
May 18, 2026
Period
May 13, 2026
Ticker
RYAM
Accession
0001597672-26-000019
Boardroom Alpha · Filing insights

Two directors elected to terms expiring in 2029. Declassification and removal of supermajority voting failed; advisory compensation, the French Sub-Plan, and auditor ratification passed.

About Rayonier Advanced Materials Inc
Market cap
$587M
1Y TSR
+133.8%
3Y TSR
+30.6%
Board grade
C+
Sector
Basic Materials
CEO
Marcus J Moeltner
Last annual meeting: May 13, 2026 · View full Rayonier Advanced Materials Inc profile →
ryam-20260513

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED)
May 13, 2026
RYAM_Logo.jpg
COMMISSION FILE NUMBER 001-36285
Incorporated in the State of Delaware
I.R.S. Employer Identification Number 46-4559529
Rayonier Advanced Materials Inc.
1301 Riverplace Boulevard, Jacksonville, Florida 32207
(Principal Executive Office)
Telephone Number: (904) 357-4600
Check the appropriate box below if the form 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions:
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:
Title of Each ClassTrading SymbolName of Exchange on which Registered
Common Stock, $0.01 par valueRYAMNew York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act



Item 5.07 Submission of Matters to a Vote of Security Holders
The 2026 Annual Meeting of Stockholders of Rayonier Advanced Materials Inc. (the “Company”) was held on May 13, 2026 (the “Annual Meeting”). At the Annual Meeting, stockholders of the Company (1) elected two director nominees to terms expiring in 2029, (2) did not approve an amendment to the Company’s Amended and Restated Certificate of Incorporation to declassify the board of directors, (3) did not approve an amendment to the Company’s Amended and Restated Certificate of Incorporation to eliminate the supermajority voting provisions, (4) approved, on an advisory basis, the compensation of the Company’s named executive officers, (5) approved the French Sub-Plan to be Implemented Under the Rayonier Advanced Materials Inc. 2023 Incentive Stock Plan, as amended and restated, and (6) ratified the selection of Grant Thornton LLP as the Company’s independent registered public accounting firm for 2026.
The final voting results were as follows:
Votes For
Votes Against
Abstain
Broker
Non-Votes
Election of Directors, Terms Expire in 2029
Charles R. Eggert
43,518,021
832,262
86,419
11,631,347
David C. Mariano
43,596,822
747,300
92,580
11,631,347
Vote on an Amendment to the Company’s Amended and Restated Certificate of Incorporation to Declassify the Board of Directors
44,009,501
377,458
49,743
11,631,347
Vote on an Amendment to the Company’s Amended and Restated Certificate of Incorporation to Eliminate the Supermajority Voting Provisions
43,819,459
588,341
28,902
11,631,347
Advisory Vote on the Compensation of our Named Executive Officers
43,491,684
674,171
270,847
11,631,347
Vote on the French Sub-Plan to be Implemented Under the Rayonier Advanced Materials Inc. 2023 Incentive Stock Plan, as Amended and Restated
40,723,763
3,634,066
78,873
11,631,347
Ratification of Auditor
55,119,872
706,501
241,676
1


Signature
Pursuant to the requirements of the Securities Exchange Act of l934, the registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.
Rayonier Advanced Materials Inc.
By:/s/ R. COLBY SLAUGHTER
R. Colby Slaughter
Senior Vice President, General Counsel and Corporate Secretary
Date: May 18, 2026
2
From this filing to the file

Every SEC filing, parsed structured.

Boardroom Alpha indexes every 8-K, 10-K, 10-Q, and proxy back to 2000 — vote tabulations, comp tables, red flags, insider transactions, all queryable the day they hit EDGAR.

Independent — issuer-pays-free, ideology-free, U.S.-owned.

More filings

Other filings from Rayonier Advanced Materials Inc (RYAM)

Reference

Frequently asked questions

When did Rayonier Advanced Materials Inc file this 8-K?
Rayonier Advanced Materials Inc (RYAM) filed this Current Report (Form 8-K) with the SEC on May 18, 2026. The accession number assigned by EDGAR is 0001597672-26-000019.
What does an 8-K disclose?
Form 8-K is the SEC's current-report form, used to disclose material events between periodic reports (10-K / 10-Q). Triggers include CEO/CFO departures, acquisitions, bankruptcies, earnings releases, auditor changes, changes in fiscal year, and amendments to corporate governance. Each 8-K is keyed to one or more Item numbers (1.01 through 9.01).
What is the key takeaway from this filing?
Two directors elected to terms expiring in 2029. Declassification and removal of supermajority voting failed; advisory compensation, the French Sub-Plan, and auditor ratification passed. This is Boardroom Alpha's one-line summary of the current report; see the full filing text above for the formal disclosure.
What Item codes does an 8-K cover?
An 8-K's Item codes (1.01 through 9.01) specify what kind of event is being disclosed — e.g. Item 1.01 for entering a material agreement, Item 5.02 for departure/election of directors and executive officers, Item 8.01 for other events. The Item codes for this 8-K appear in the filing text above.
Where can I find Rayonier Advanced Materials Inc's prior current reports on EDGAR?
The SEC EDGAR browser lists every 8-K Rayonier Advanced Materials Inc has filed under CIK 1597672, sortable by date. Use the "View on SEC EDGAR" link in the page header, or browse directly via https://www.sec.gov/cgi-bin/browse-edgar.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer